Omeros Corporation today announced the closing of the asset sale and licensing transaction between Omeros and Novo Nordisk for the candidate drug zaltenibart (formerly OMS906). Zaltenibart is a ...

The ten steps in this first-time home-buying checklist will help you understand exactly what to expect during your first real ...

In 2025, Cape Town's property market showcased a striking dichotomy: from record-breaking luxury sales to a burgeoning ...

KASIKORN LEASING Co., Ltd. (KLeasing) is offering special year-end promotions at the 42nd Thailand International Motor Expo ...